Anna Gotzamani‐Psarrakou

470 total citations
36 papers, 343 citations indexed

About

Anna Gotzamani‐Psarrakou is a scholar working on Neurology, Cognitive Neuroscience and Oncology. According to data from OpenAlex, Anna Gotzamani‐Psarrakou has authored 36 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 8 papers in Cognitive Neuroscience and 6 papers in Oncology. Recurrent topics in Anna Gotzamani‐Psarrakou's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Vitamin D Research Studies (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Anna Gotzamani‐Psarrakou is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Vitamin D Research Studies (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Anna Gotzamani‐Psarrakou collaborates with scholars based in Greece, United States and Norway. Anna Gotzamani‐Psarrakou's co-authors include John G. Yovos, Efstratios Moralidis, Panagiotis Ioannidis, Dimitrios T. Karamitsos, Dimitri P. Mikhailidis, Dimitrios Karacostas, Niki Katsiki, Durval C. Costa, Sevasti Bostantjopoulou and Marianthi Arnaoutoglou and has published in prestigious journals such as International Journal of Cancer, European Journal of Endocrinology and Lung Cancer.

In The Last Decade

Anna Gotzamani‐Psarrakou

34 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Gotzamani‐Psarrakou Greece 12 98 58 54 43 42 36 343
Barbara Di Pietro Italy 15 53 0.5× 74 1.3× 96 1.8× 30 0.7× 47 1.1× 17 394
Alicia Zha United States 13 69 0.7× 99 1.7× 22 0.4× 22 0.5× 26 0.6× 33 421
Kayıhan Uluç Türkiye 12 155 1.6× 51 0.9× 57 1.1× 29 0.7× 53 1.3× 49 406
Yangyang Wang China 11 56 0.6× 39 0.7× 67 1.2× 31 0.7× 68 1.6× 40 416
Mei-Ting Zhuang China 10 71 0.7× 74 1.3× 52 1.0× 40 0.9× 151 3.6× 17 387
Martin Heier Norway 15 80 0.8× 69 1.2× 53 1.0× 152 3.5× 17 0.4× 32 680
Yasuko Tatewaki Japan 13 133 1.4× 75 1.3× 98 1.8× 11 0.3× 36 0.9× 52 427
Joseph Mettenburg United States 11 68 0.7× 72 1.2× 86 1.6× 14 0.3× 73 1.7× 33 407
JS Meyer United States 10 111 1.1× 39 0.7× 78 1.4× 86 2.0× 102 2.4× 16 454
D. Birchall United Kingdom 10 129 1.3× 42 0.7× 29 0.5× 23 0.5× 54 1.3× 15 410

Countries citing papers authored by Anna Gotzamani‐Psarrakou

Since Specialization
Citations

This map shows the geographic impact of Anna Gotzamani‐Psarrakou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gotzamani‐Psarrakou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gotzamani‐Psarrakou more than expected).

Fields of papers citing papers by Anna Gotzamani‐Psarrakou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gotzamani‐Psarrakou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gotzamani‐Psarrakou. The network helps show where Anna Gotzamani‐Psarrakou may publish in the future.

Co-authorship network of co-authors of Anna Gotzamani‐Psarrakou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gotzamani‐Psarrakou. A scholar is included among the top collaborators of Anna Gotzamani‐Psarrakou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gotzamani‐Psarrakou. Anna Gotzamani‐Psarrakou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gotzamani‐Psarrakou, Anna, et al.. (2024). Apraxia Patterns for the Differentiation between Alzheimer’s Disease and Frontotemporal Dementia Variants. Medicina. 60(3). 435–435.
2.
Koufakis, Theocharis, et al.. (2022). The effect of vitamin D supplementation on glycemic status of elderly people with prediabetes: a 12-month open-label, randomized-controlled study. Expert Review of Clinical Pharmacology. 15(1). 89–97. 9 indexed citations
3.
Natsis, Konstantinos, et al.. (2021). Preliminary validation of the apraxia battery for adults-second edition (ABA-2) in Greek patients with dementia. Acta Neurologica Belgica. 122(4). 997–1003. 3 indexed citations
4.
Gotzamani‐Psarrakou, Anna, et al.. (2016). The role of serum osteoprotegerine in metastatic prostate cancer - a case control study.. PubMed. 20(2). 133–138. 2 indexed citations
5.
Ioannidis, Panagiotis, et al.. (2015). Adaptation of the Cognitive Reserve Index Questionnaire (CRIq) for the Greek population. Neurological Sciences. 37(4). 633–636. 29 indexed citations
6.
Toulis, Konstantinos A., Triantafyllos Didangelos, Anna Gotzamani‐Psarrakou, et al.. (2015). Thyroid Autoimmunity in the Context of Type 2 Diabetes Mellitus: Implications for Vitamin D. International Journal of Endocrinology. 2015. 1–5. 16 indexed citations
7.
Gotzamani‐Psarrakou, Anna, et al.. (2013). Imaging beyond the striatonigral dopaminergic system in Parkinson's disease.. PubMed. 15(3). 224–32. 14 indexed citations
8.
Moralidis, Efstratios, et al.. (2013). A multicenter evaluation of the appropriate use of single-photon emission tomography myocardial perfusion imaging in Greece. Journal of Nuclear Cardiology. 20(2). 275–283. 10 indexed citations
9.
Costa, Durval C., et al.. (2012). SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease?. Annals of Nuclear Medicine. 26(4). 337–344. 36 indexed citations
10.
Gotzamani‐Psarrakou, Anna, et al.. (2011). Radiation exposure to patients and radiologists during interventional procedures. Radiation Protection Dosimetry. 147(1-2). 86–89. 13 indexed citations
11.
Zarogoulidis, Paul, Theodoros Kontakiotis, Paul Zarogoulidis, et al.. (2011). Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients. Lung Cancer. 76(1). 84–88. 25 indexed citations
12.
Yavropoulou, Maria P., Olympia E. Anastasiou, Pantelis Zebekakis, et al.. (2011). Response of biochemical markers of bone turnover to oral glucose load in diseases that affect bone metabolism. European Journal of Endocrinology. 164(6). 1035–1041. 19 indexed citations
13.
Moralidis, Efstratios, et al.. (2010). Hypertrophic osteoarthropathy manifested with isolated calcaneal periostitis in bone scintigraphy. Annals of Nuclear Medicine. 24(4). 313–317. 6 indexed citations
14.
15.
Κεσίσογλου, Ισαάκ, et al.. (2008). Impact of Porcine Orexin a on Glucagon Plasma Concentrations in Pigs. International Journal of Immunopathology and Pharmacology. 21(3). 527–538. 3 indexed citations
16.
Gotzamani‐Psarrakou, Anna, et al.. (2008). Right inferior parietal region hypoperfusion as a reflection of anosognosia in dementia. Annals of General Psychiatry. 7(S1). 1 indexed citations
17.
Gotzamani‐Psarrakou, Anna, et al.. (2007). Evaluation of Dopaminergic Function in Frontotemporal Dementia Using <sup>123</sup>I-FP-CIT Single Photon Emission Computed Tomography. Neurodegenerative Diseases. 4(5). 382–385. 23 indexed citations
18.
Κεσίσογλου, Ισαάκ, et al.. (2007). The Effect of Porcine Orexin a on C-Peptide Plasma Concentrations in Pigs. European Journal of Inflammation. 5(3). 129–139.
19.
Costa, Durval C., et al.. (2006). Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.. PubMed. 9(2). 147–53. 10 indexed citations
20.
Zamboulis, Chrysanthos, et al.. (1996). Effects of Fosinopril on Renal Function in Patients with Mild to Moderate Essential Hypertension. Clinical Drug Investigation. 12(5). 251–258. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Di Pietro Breakdown of academic impact, for papers by Alicia Zha Breakdown of academic impact, for papers by Kayıhan Uluç Breakdown of academic impact, for papers by Yangyang Wang Breakdown of academic impact, for papers by Mei-Ting Zhuang Breakdown of academic impact, for papers by Martin Heier Breakdown of academic impact, for papers by Yasuko Tatewaki Breakdown of academic impact, for papers by Joseph Mettenburg Breakdown of academic impact, for papers by JS Meyer Breakdown of academic impact, for papers by D. Birchall
Rankless by CCL
2026